Search results for abx831507
Showing 1 – 10 of1products
ID: BAB977781689
Vofatamab, Abbexa, abx831507
Vofatamab is a monoclonal antibody biosimilar expressed in CHO cells, targeting FGFR3, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Vofatamab is under investigation in clinical trial NCT02401542 (Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma).
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Request a product
Please provide the required information below so that we can quickly source your products.